HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Myopia 9

Also Known As:

MYP9

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Eye Diseases: 3522
- Refractive Errors: 3499
  - Myopia: 8363
    - Myopia 9: 2

Related Diseases

1.	Myopia
2.	Macular Degeneration (Age-Related Maculopathy)
3.	Polypoidal Choroidal Vasculopathy

Experts

1.	Harder, Björn C: 1 article (06/2013)
2.	Jendritza, Bettina: 1 article (06/2013)
3.	Jendritza, Waldemar: 1 article (06/2013)
4.	Jonas, Jost B: 1 article (06/2013)
5.	Schlichtenbrede, Frank C: 1 article (06/2013)
6.	von Baltz, Stefan: 1 article (06/2013)
7.	Ishikawa, Kohei: 1 article (12/2003)
8.	Miyake, Kensaku: 1 article (12/2003)
9.	Miyake, Yozo: 1 article (12/2003)
10.	Nakamura, Makoto: 1 article (12/2003)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Myopia 9:

1.	Fluorescein (Funduscein)FDA LinkGeneric 12/01/2003 - "Optical coherence tomography and fluorescein angiography were performed before and 6 to 15 months (mean +/- standard error [SE], 10.4+/-0.7) after macular translocation surgery with a 360 degrees retinotomy in 23 patients, ages 48 to 79 years, with age-related macular degeneration (12 eyes), polypoidal choroidal vasculopathy (2 eyes), and high myopia (9 eyes). "
2.	Bevacizumab (Avastin)FDA Link 06/01/2013 - "Prevalence of moderate myopia (17% ± 8% vs 54% ± 10%; P = .02; OR: 0.18 [95% CI: 0.05, 0.68]) and high myopia (9% ± 6% vs 42% ± 10%; P = .01; OR: 0.13 [95% CI: 0.03, 0.67]) was significantly lower in the bevacizumab group. "